Welcome to our dedicated page for Sharps Tech SEC filings (Ticker: STSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sharps Technology Inc. filings document 8-K material events for a Nevada operating company with common stock and warrant-related securities. The company's current reports cover material definitive agreements, governance amendments, special meeting voting results, stockholder proposal procedures, exclusive forum provisions, and updates to its code of business conduct and ethics.
The filing record also documents capital-structure and corporate-action disclosures, including a share repurchase program and broker agreement, strategic advisor lock-up terms, warrant-related share issuance approvals, registration-rights deadline waivers, interim finance leadership arrangements, indemnification agreements, and litigation settlement disclosures involving assets, subsidiary interests, patents and trademarks.
Sharps Technology Inc. large shareholder Saba Capital Management, L.P. reported two sales of the company’s common stock. On January 13, 2026, Saba Capital sold 29,777 shares at a price of $2.19 per share. On January 14, 2026, it sold another 77,688 shares at $2.25 per share. After these indirect transactions, Saba Capital reported beneficial ownership of 1,626,858 shares following the first sale and 1,549,170 shares following the second sale.
Saba Capital Management, L.P. has filed an initial ownership report as a 10% owner of Sharps Technology Inc. (STSS) as of 01/09/2026. The filing shows indirect beneficial ownership of 1,656,635 shares of common stock.
Saba Capital also indirectly holds cash stapled warrants exercisable into 1,538,462 shares of common stock at an exercise price of $9.75, expiring on 11/04/2028, and pre-funded warrants for 388,462 shares of common stock at $6.50 per share, noted as expiring when exercised in full.
Sharps Technology (STSS) filed its Q3 2025 10‑Q, highlighting a major shift to a digital‑asset treasury anchored in Solana (SOL). As of September 30, total assets were $443.96M, including SOL at fair value of $404.20M and USDC of $14.70M. Cash was $10.52M. Management states current liquidity is sufficient for the next twelve months and no longer raises substantial doubt about going concern.
Operations reflected the pivot: product revenue was $83,622, and staking revenue was $2,205,423. The quarter included significant operating costs, including selling, general and administrative expenses of $110.72M and a $7.50M impairment of fixed assets tied to the exit from manufacturing, resulting in a net loss of $105.33M. A 10% change in SOL prices would have impacted income by about $40.4M for the period, underscoring market sensitivity.
Financing activity was robust, with $210.73M of net cash provided year‑to‑date. The company received $144.04M of digital assets and $86.10M of USDC from common stock issuances. Shares outstanding were 27,626,498 at quarter‑end and 28,226,153 as of November 14, 2025. Sharps now reports two segments: Medical Device Packaging Products and Digital Assets.
Sharps Technology, Inc. (Nasdaq: STSS) filed a resale registration statement covering shares issued in a private placement and shares underlying multiple warrant classes. This prospectus permits Selling Stockholders to offer and resell: 24,338,649 common shares, plus warrant shares including 13,884,617 from cash pre‑funded warrants (exercise price $0.0001), 38,223,266 from cash stapled warrants (exercise price $9.75), 24,836,560 from cryptocurrency pre‑funded warrants (exercise price $0.0001), 24,836,560 from cryptocurrency stapled warrants (exercise price $9.75), and 6,321,367 from strategic advisor warrants (exercise price $0.0001).
The company is not selling shares and will not receive proceeds from Selling Stockholder sales. It could receive up to $614,837,807.75 in gross proceeds if all warrants are exercised. Shares outstanding were 28,226,153 as of October 17, 2025. The company highlights extensive risk factors tied to its SOL-focused digital asset treasury strategy, staking operations, market volatility, custody, DeFi usage, and evolving regulation.
Sharps Technology (STSS) reported results of its special meeting of stockholders. Of 26,600,848 shares eligible to vote as of September 16, 2025, 17,779,090 shares were present or represented by proxy, establishing a 66.9% quorum.
Stockholders elected Annemarie Tierney as director with 17,770,289 votes for and 8,801 withheld. Proposal 2 was approved with 17,750,927 votes for, 27,713 against, and 450 abstentions. Proposal 3 was approved with 17,743,259 votes for, 35,546 against, and 285 abstentions. Proposal 4 was approved with 16,802,916 votes for, 51,835 against, and 924,339 abstentions.
Sharps Technology, Inc. approved a 2025 share repurchase program authorizing the company to buy back up to $100,000,000 of its outstanding common stock. The program allows repurchases in the open market and through negotiated transactions, with the amount and timing of purchases depending on available capital, financial and operational performance, market conditions, securities law limits, and other factors, and does not obligate the company to repurchase any shares.
To facilitate these buybacks, Sharps Technology entered into an Open Market Share Repurchase Agreement with Cantor Fitzgerald & Co., which will act as a non-exclusive agent to repurchase shares under Rule 10b-18 of the Exchange Act. The agreement remains in effect until either party terminates it by written notice, and the company will pay the broker a commission of $0.02 per share repurchased.
Sharps Technology, Inc. disclosed that its Board of Directors has authorized a stock repurchase program. This program allows the company to buy back its common shares in the open market and through negotiated transactions, which can reduce the number of shares available in the market over time. The announcement was made via a press release dated October 2, 2025, which is included as an exhibit to the report.
Reporting person Zhang Yuwen, Chief Investment Officer and director of Sharps Technology Inc. (STSS), reported a grant of stock options on 08/23/2025. The award consists of 500,000 stock options with an exercise price of $6.41 per share and a ten‑year term expiring on 08/22/2035. The options vest in four equal installments of 125,000 shares each, with 25% vesting every three months beginning on 08/23/2025. Following the grant, the reporting person beneficially owns 500,000 underlying common shares attributable to the options, held directly.
Sharps Technology Inc. (STSS) director and Chief Investment Officer Yuwen Zhang filed an initial Form 3 reporting indirect beneficial ownership of 14,040 shares of common stock that are held indirectly through a spouse. The event date listed is 08/23/2025 and the form is signed on 10/06/2025. No derivative securities (options, warrants, convertible instruments) are reported on this filing. The filing confirms the reporting person’s roles as a director and an officer (Chief Investment Officer), and discloses a pecuniary interest in the shares through family ownership.
Sharps Technology, Inc. entered into a confidential settlement agreement to resolve litigation with Barry Berler and several Plasto-related entities.
Under this settlement, Sharps will transfer certain assets to Plasto Technology Group LLC, including all of its right, title and interest in the issued and outstanding shares of its Hungarian subsidiary, Safegard Medical Kft, as well as specified patents, registered trademarks and associated goodwill.
All parties agree to unconditionally and irrevocably release one another and their representatives from all claims in the litigation, and the agreement specifies that no party admits fault, responsibility or liability. Sharps also provides unaudited pro forma condensed consolidated financial information as an exhibit to show the impact of these changes.